Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Dartmouth-hitchcock researchers find hormone decreases need for blood transfusions

11.12.2002


Results of a 2 ½ year study led by doctors at Dartmouth-Hitchcock Medical Center could have implications for the nation’s decreasing blood supply.



In an article published in the December 11 issue of the Journal of the American Medical Association (JAMA), Drs. Howard L Corwin and Andrew Gettinger describe the effects of administering recombinant human erythropoietin (rHuEPO) to critically ill patients. Significantly, they found that use of the hormone, which stimulates red blood cell production, resulted in a 19 percent reduction in red blood cell transfusion to those patients.

The double-blind, placebo-controlled trial was conducted at 65 centers between December 1998 and June 2001. 1,302 patients who had been in the Intensive Care Unit (ICU) for two days and were expected to be in ICU for at least two more days, were enrolled. Patients were randomly assigned to receive either 40,000 units of rHuEPO or placebo on day three in the ICU. These doses then continued weekly.


The study found that patients who received rHuEPO were less likely to need a transfusion of red blood cells and showed a greater increase in hemoglobin. "Weekly therapy with 40,000 units of rHuEPO in critically ill patients results in a significant reduction in their exposure to … RBC tranfusions," the authors wrote.

Current estimates are that 35-50 percent of all patients admitted to ICU’s in the U.S. and Western Europe receive almost 5 RBC units during their ICU stay. Concern about infection and suppression of the immune system as a result of transfusions have led doctors to seek alternatives that would reduce these risks, while not neglecting the anemia that is common in ICU patients.

"The view of RBC transfusion as risk-free is no longer tenable," the authors note. "Adding to the controversy about risk-benefit ratio for RBC transfusion are recent data showing that an aggressive RBC transfusion strategy may decrease the likelihood of survival in selected subgroups of critically ill adults."

Reducing reliance on blood transfusions could have many benefits, according to the authors: "Not transfusing "unnecessary" units of RBC avoids the morbidity and mortality directly associated with each RBC unit transfused, as well as the potential for medical errors associated with the transfusion process itself." And, referring to the state of the nation’s blood supply, they write, "The avoidance of unnecessary blood transfusions would also save a resource that is becoming increasingly scarce."

While further study is needed to assess the cost-effectiveness of the therapy, as well as its effects on clinical outcomes, Dr. Gettinger is encouraged that initial findings may lead to improved results for critically-ill patients, and lessen reliance on blood transfusion generally: "The standard of care in manging the anemia in critically ill patients has always been to tranfuse allogeneic blood," he said. "As risks of allogeneic blood are better understood, the opportunity to treat anemia with a non-blood product alternative and decrease the dependence on an increasingly scarce resource is significant."


###
Dartmouth-Hitchcock Medical Center (DHMC) is an integrated academic medical center located on a 225-acre campus in the heart of New Hampshire’s Upper Connecticut River Valley in Lebanon. DHMC comprises Mary Hitchcock Memorial Hospital (a 396-bed tertiary care hospital), the Dartmouth-Hitchcock Clinic (a network of more than 900 primary and specialty care physicians located throughout New Hampshire and Vermont), Dartmouth Medical School and the Veteran’s Affairs Medical Center Memorial Hospital in White River Junction, VT.

Deborah Kimbell | EurekAlert!
Further information:
http://www.dartmouth.edu/

More articles from Health and Medicine:

nachricht How prenatal maternal infections may affect genetic factors in Autism spectrum disorder
22.03.2017 | University of California - San Diego

nachricht Camouflage apples
22.03.2017 | Empa - Eidgenössische Materialprüfungs- und Forschungsanstalt

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Pulverizing electronic waste is green, clean -- and cold

22.03.2017 | Materials Sciences

Astronomers hazard a ride in a 'drifting carousel' to understand pulsating stars

22.03.2017 | Physics and Astronomy

New gel-like coating beefs up the performance of lithium-sulfur batteries

22.03.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>